StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Illumina, Inc.
NasdaqGS:ILMN
Sector
Location
Market Cap
USD 15.84 B
Share Price
USD 100.05
Avg Daily Volume
2,245,335
Change (1 day)
2.68%
Change (1 year)
-11.59%
Change (YTD)
-25.13%
Illumina, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 30, 2025: USD 1.00 B
Illumina, Inc. Operating Cash Flow is USD 1.00 B for the Trailing 12 Months (TTM) ending March 30, 2025, a 83.82% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Illumina, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 544.00 M, a 136.52% change year over year.
-
Illumina, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending April 02, 2023 was USD 230.00 M, a -47.13% change year over year.
-
Illumina, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending April 03, 2022 was USD 435.00 M, a -59.76% change year over year.
-
Illumina, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending April 04, 2021 was USD 1.08 B, a -4.67% change year over year.
Competitors
Natera, Inc.
USD 163.36
NTRA
+1.61
1.00%
Tempus AI, Inc.
USD 59.60
TEM
+1.19
2.04%
Veracyte, Inc.
USD 27.52
VCYT
+0.44
1.62%
Schrödinger, Inc.
USD 21.71
SDGR
+0.02
0.09%
Azenta, Inc.
USD 34.15
AZTA
+0.78
2.34%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
RELX Plc
USD 54.15
REL.L
+0.69
1.29%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Natera, Inc.
USD 163.36
NTRA
+1.61
1.00%
Tempus AI, Inc.
USD 59.60
TEM
+1.19
2.04%
Veracyte, Inc.
USD 27.52
VCYT
+0.44
1.62%
Schrödinger, Inc.
USD 21.71
SDGR
+0.02
0.09%
Azenta, Inc.
USD 34.15
AZTA
+0.78
2.34%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
RELX Plc
USD 54.15
REL.L
+0.69
1.29%